Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-09-20

Clinical Trial Update: A Trial for Prevention of Recurrent Ischemic Priapism in Men With Sickle Cell Disease: A Pilot Study [Phase 2]

View source ↗

Summary

A Phase 2 pilot trial, sponsored by Vanderbilt University Medical Center, evaluated prevention of recurrent ischemic priapism in men with sickle cell disease an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Priapism Due to Sickle Cell Disease | Phase 2 | Status: COMPLETED